Reply to López-Campos et al.: Triple-Therapy Trials for Chronic Obstructive Pulmonary Disease: Methodological Considerations in the Mortality Effect.

Overview

authors

Lipson, David A

Martinez, Fernando J

publication date

April 1, 2021

published in

American journal of respiratory and critical care medicine Journal

Research

keywords

Chlorobenzenes
Pulmonary Disease, Chronic Obstructive

Identity

PubMed Central ID

PMC8017567

Scopus Document Identifier

85103802021

Digital Object Identifier (DOI)

10.1164/rccm.202012-4494LE

PubMed ID

33444516

Additional Document Info

volume

203

issue

7